Home
>
National Drug Code (NDC)
>
Etoposide
Etoposide - 63323-104-50 - (ETOPOSIDE)
Drug Information of Etoposide
| Product NDC: | 63323-104 |
| Proprietary Name: | Etoposide |
| Non Proprietary Name: | ETOPOSIDE |
| Active Ingredient(s): | 20 mg/mL & nbsp; ETOPOSIDE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Etoposide
| Product NDC: | 63323-104 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074983 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20010718 |
Package Information of Etoposide
| Package NDC: | 63323-104-50 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-104-50) > 50 mL in 1 VIAL, MULTI-DOSE |
NDC Information of Etoposide
| NDC Code | 63323-104-50 |
| Proprietary Name | Etoposide |
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-104-50) > 50 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 63323-104 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ETOPOSIDE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20010718 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | ETOPOSIDE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
